πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 9 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12246027

Compositions of bile acids and phenylbutyrate compounds

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12186330

Compositions for improving cell viability and methods of use thereof

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12138272

Methods and compositions for treating amyotrophic lateral sclerosis

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11583542

Compositions of bile acids and phenylbutyrate compounds

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11559533

Compositions of bile acids and phenylbutyrate compounds

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11071742

Compositions for improving cell viability and methods of use thereof

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10857162

Compositions for improving cell viability and methods of use thereof

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10251896

Compositions for improving cell viability and methods of use thereof

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9872865

Compositions for improving cell viability and methods of use thereof

Amylyx Pharmaceuticals, Inc. Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted